1Mitchell, AJ, Chan, M, Bhatti, H, Halton, M, Grassi, L, Johansen, C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160–74.
2Lloyd-Williams, M, Shiels, C, Taylor, F, Dennis, M. Depression: an independent predictor of early death in patients with advanced cancer. J Affect Disord 2009; 113: 127–32.
3National Institute for Health and Care Excellence. Improving Outcomes in Supportive and Palliative Care for Adults with Cancer. NICE, 2004.
4Pitman, A, Suleman, S, Hyde, N, Hodgkiss, A. Depression and anxiety in patients with cancer. BMJ 2018; 361: k1415.
5Price, A, Hotopf, M. The treatment of depression in patients with advanced cancer undergoing palliative care. Curr Opin Support Palliat Care 2009; 3: 61–6.
6Mustafa, M, Carson-Stevens, A, Gillespie, D, Edwards, AG. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev 2013; 6: CD004253.
7Serfaty, M, King, M, Nazareth, I, Moorey, S, Aspden, T, Tookman, A, et al. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. Health Technol Assess 2019; 23(19): 1–106.
8Serfaty, M, King, M, Nazareth, I, Tookman, A, Wood, J, Gola, A, et al. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial. Trials 2016; 17: 113.10.1186/s13063-016-1223-6
9Kroenke, K, Spitzer, RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002; 32: 509–15.
10Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20): 22–33.
11Saunders, JB, Aasland, OG, Babor, TF, de la Fuente, JR, Grant, M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88: 791–804.10.1111/j.1360-0443.1993.tb02093.x
12Department of Health. Talking Therapies: A Four-Year Plan of Action. Department of Health, 2011.
13Beck, AT. Cognitive Therapy of Depression. Guilford Press, 1979.
14Blackburn, I-M, James, IA, Milne, DL, Baker, C. The Revised Cognitive Therapy Scale (CTS-R): psychometric properties. Behav Cogn Psychother 2001; 29: 431–46.
15Beck, A, Steer, R, Brown, G. BDI-II, Beck Depression Inventory: Manual. Psychological Corporation, 1996.
16Laidlaw, T, Bennett, BM, Dwivedi, P, Naito, A, Gruzelier, J. Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or Johrei: a short report. Contemp Hypn 2005; 22: 84–93.10.1002/ch.27
17Kroenke, K, Spitzer, RL, Williams, JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–13.10.1046/j.1525-1497.2001.016009606.x
18Brooks, R. EuroQol: the current state of play. Health Policy 1996; 37: 53–72.
19King, M, Jones, L, Richardson, A, Murad, S, Irving, A, Aslett, H, et al. The relationship between patients’ experiences of continuity of cancer care and health outcomes: a mixed methods study. Br J Cancer 2008; 98: 529–36.
20Oken, MM, Creech, RH, Tormey, DC, Horton, J, Davis, TE, McFadden, ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–56.10.1097/00000421-198212000-00014
21Bollini, P, Pampallona, S, Tibaldi, G, Kupelnick, B, Munizza, C. Effectiveness of antidepressants: meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry 1999; 174: 297–303.
22Kessler, D, Lewis, G, Kaur, S, Wiles, N, King, M, Weich, S, et al. Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet 2009; 374: 628–34.10.1016/S0140-6736(09)61257-5
23Sussman, J, Hayward, R. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 2009; 340: c2073.
24Hayasaka, Y, Purgato, M, Magni, LR, Ogawa, Y, Takeshima, N, Cipriani, A, et al. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord 2015; 180: 179–84.10.1016/j.jad.2015.03.021
25Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009; 77: 775–87.
26Walker, J, Hansen, CH, Martin, P, Symeonides, S, Gourley, C, Wall, L, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol 2014; 15: 1168–76.
27Rodin, G, Lo, C, Rydall, A, Shnall, J, Malfitano, C, Chiu, A, et al. Managing Cancer And Living Meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer. J Clin Oncol 2018; 36: 2422–32.
28Kroenke, K. Enhancing the clinical utility of depression screening. Can Med Assoc J 2012; 184: 281–2.10.1503/cmaj.112004
29Cuijpers, P, Berking, M, Andersson, G, Quigley, L, Kleiboer, A, Dobson, KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 2013; 58: 376–85.10.1177/070674371305800702
30Savard, J, Simard, S, Giguère, I, Ivers, H, Morin, CM, Maunsell, E, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 2006; 4: 219–37.
31Moorey, S, Cort, E, Kapari, M, Monroe, B, Hansford, P, Mannix, K, et al. A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol Med 2009; 39: 713–23.10.1017/S0033291708004169
32Hassan, S, Bennett, K, Serfaty, M. Delivering cognitive behavioural therapy to advanced cancer patients: a qualitative exploration into therapists’ experiences within a UK psychological service. Clin Psychol Psychother 2018; Mar 25: doi 10.1002/cpp.2190 [Epub ahead of print].
33Department of Health. A Mandate from the Government to NHS England: April 2014 to March 2015. Department of Health, 2015.
34Glover, G, Webb, M, Evison, F. Improving Access to Psychological Therapies: A Review of the Progress Made by Sites in the First Roll-Out Year. North East Public Health Observatory, 2010.
35Ostuzzi, G, Matcham, F, Dauchy, S, Barbui, C, Hotopf, M. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev 2018; 4: CD011006.